PyIgClassify2: Canonical Clusters of Antibody CDR Loop Conformations

PyIgClassify2: Classification of Antibody CDR Conformations

CDRs for query 6FYS

#CDRs = 4; #Clusters = 5.
Chain	Gene	PDB Species	Frame Germline	Frame %	CDR Germline	CDR %	CDR	Length	Cluster	Distance(°)	Sequence	Ramachandran
A	heavy	Lama.glama	La_IGHV1S1*01_VHH	87.7	La_IGHV1S1*01_VHH	69.2	H1	13	H1-13-*	-1	AATGFTLENKAIG	BBAABBAAABBBB
A	heavy	Lama.glama	La_IGHV1S1*01_VHH	87.7	La_IGHV1S1*01_VHH	60.0	H2	10	H2-10-*	-1	CISKSGSWTY	BBBAALBBBB
A	heavy	Lama.glama	La_IGHV1S1*01_VHH	87.7	La_IGHV1S1*01_VHH	50.0	H3	22	H3-22-*	-1	ATTTAggglcwdgTTFSRLASS
A	heavy	Lama.glama	La_IGHV1S1*01_VHH	87.7	La_IGHV1S1*01_VHH	87.5	H4	8	H4-8-1	8	RDNAENTV	BBAAALBB
B	heavy	Lama.glama	La_IGHV1S1*01_VHH	87.7	La_IGHV1S1*01_VHH	69.2	H1	13	H1-13-1	17	AATGFTLENKAIG	BBBLBBAAABBBB
B	heavy	Lama.glama	La_IGHV1S1*01_VHH	87.7	La_IGHV1S1*01_VHH	60.0	H2	10	H2-10-*	-1	CISKSGSWTY	BBBAALBBBB
B	heavy	Lama.glama	La_IGHV1S1*01_VHH	87.7	La_IGHV1S1*01_VHH	50.0	H3	22	H3-22-*	-1	ATTTAggglcwdgTTFSRLASS
B	heavy	Lama.glama	La_IGHV1S1*01_VHH	87.7	La_IGHV1S1*01_VHH	87.5	H4	8	H4-8-1	11	RDNAENTV	BBAAALBB
C	heavy	Lama.glama	La_IGHV1S1*01_VHH	87.7	La_IGHV1S1*01_VHH	69.2	H1	13	H1-13-1	15	AATGFTLENKAIG	BBBLBBAAABBBB
C	heavy	Lama.glama	La_IGHV1S1*01_VHH	87.7	La_IGHV1S1*01_VHH	60.0	H2	10	H2-10-*	-1	CISKSGSWTY	BBBAALBBBB
C	heavy	Lama.glama	La_IGHV1S1*01_VHH	87.7	La_IGHV1S1*01_VHH	50.0	H3	22	H3-22-*	-1	ATTTAggglcwdgTTFSRLASS
C	heavy	Lama.glama	La_IGHV1S1*01_VHH	87.7	La_IGHV1S1*01_VHH	87.5	H4	8	H4-8-1	9	RDNAENTV	BBAAALBB
D	heavy	Lama.glama	La_IGHV1S1*01_VHH	87.7	La_IGHV1S1*01_VHH	69.2	H1	13	H1-13-1	15	AATGFTLENKAIG	BBBLBBAAABBBB
D	heavy	Lama.glama	La_IGHV1S1*01_VHH	87.7	La_IGHV1S1*01_VHH	60.0	H2	10	H2-10-*	-1	CISKSGSWTY	BBBAALBBBB
D	heavy	Lama.glama	La_IGHV1S1*01_VHH	87.7	La_IGHV1S1*01_VHH	50.0	H3	22	H3-22-*	-1	ATTTAggglcwdgTTFSRLASS
D	heavy	Lama.glama	La_IGHV1S1*01_VHH	87.7	La_IGHV1S1*01_VHH	87.5	H4	8	H4-8-1	8	RDNAENTV	BBAAALBB
E	heavy	Lama.glama	La_IGHV1S1*01_VHH	87.7	La_IGHV1S1*01_VHH	69.2	H1	13	H1-13-1	13	AATGFTLENKAIG	BBBLBBAAABBBB
E	heavy	Lama.glama	La_IGHV1S1*01_VHH	87.7	La_IGHV1S1*01_VHH	60.0	H2	10	H2-10-*	-1	CISKSGSWTY	BBBAALBBBB
E	heavy	Lama.glama	La_IGHV1S1*01_VHH	87.7	La_IGHV1S1*01_VHH	50.0	H3	22	H3-22-*	-1	ATTTAggglcwdgTTFSRLASS
E	heavy	Lama.glama	La_IGHV1S1*01_VHH	87.7	La_IGHV1S1*01_VHH	87.5	H4	8	H4-8-1	9	RDNAENTV	BBAAALBB
F	heavy	Lama.glama	La_IGHV1S1*01_VHH	87.7	La_IGHV1S1*01_VHH	69.2	H1	13	H1-13-1	11	AATGFTLENKAIG	BBBLBBAAABBBB
F	heavy	Lama.glama	La_IGHV1S1*01_VHH	87.7	La_IGHV1S1*01_VHH	60.0	H2	10	H2-10-*	-1	CISKSGSWTY	BBBAALBBBB
F	heavy	Lama.glama	La_IGHV1S1*01_VHH	87.7	La_IGHV1S1*01_VHH	50.0	H3	22	H3-22-*	-1	ATTTAggglcwdgTTFSRLASS
F	heavy	Lama.glama	La_IGHV1S1*01_VHH	87.7	La_IGHV1S1*01_VHH	87.5	H4	8	H4-8-1	10	RDNAENTV	BBAAALBB
G	heavy	Lama.glama	La_IGHV1S1*01_VHH	87.7	La_IGHV1S1*01_VHH	69.2	H1	13	H1-13-1	15	AATGFTLENKAIG	BBBLBBAAABBBB
G	heavy	Lama.glama	La_IGHV1S1*01_VHH	87.7	La_IGHV1S1*01_VHH	60.0	H2	10	H2-10-*	-1	CISKSGSWTY	BBBAALBBBB
G	heavy	Lama.glama	La_IGHV1S1*01_VHH	87.7	La_IGHV1S1*01_VHH	50.0	H3	22	H3-22-*	-1	ATTTAggglcwdgTTFSRLASS
G	heavy	Lama.glama	La_IGHV1S1*01_VHH	87.7	La_IGHV1S1*01_VHH	87.5	H4	8	H4-8-1	12	RDNAENTV	BBAAALBB
H	heavy	Lama.glama	La_IGHV1S1*01_VHH	87.7	La_IGHV1S1*01_VHH	69.2	H1	13	H1-13-1	16	AATGFTLENKAIG	BBBLBBAAABBBB
H	heavy	Lama.glama	La_IGHV1S1*01_VHH	87.7	La_IGHV1S1*01_VHH	60.0	H2	10	H2-10-*	-1	CISKSGSWTY	BBBAALBBBB
H	heavy	Lama.glama	La_IGHV1S1*01_VHH	87.7	La_IGHV1S1*01_VHH	50.0	H3	22	H3-22-*	-1	ATTTAggglcwdgTTFSRLASS
H	heavy	Lama.glama	La_IGHV1S1*01_VHH	87.7	La_IGHV1S1*01_VHH	87.5	H4	8	H4-8-1	8	RDNAENTV	BBAAALBB

Site developed by the Antibody Team at the lab of Roland Dunbrack. Last updated on Oct. 13, 2022